Benjamin Weigel
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Microbial Natural Products and Biosynthesis 5
-
- Plant biochemistry and biosynthesis 3
- Co-authors
- Thomas D. Ingolia (2 shared papers)Martin D. Tobin (1 shared paper)S Kovacevic (1 shared paper)James R. Miller (1 shared paper)Stanley G. Burgett (1 shared paper)Paul L. Skatrud (1 shared paper)S. W. QUEENER (1 shared paper)Charles A. Frolik (1 shared paper)
- Journals
- Journal of Bacteriology (2 papers)ChemBioChem (1 paper)The Plant Cell (1 paper)Journal of Biological Chemistry (1 paper)Current Opinion in Chemical Biology (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Benjamin Weigel
10 papers receiving 426 citations
Peers
Comparison fields: 5 of 61
- Molecular Medicine 50
- Pharmacology 156
- Microbiology 5
- Molecular Biology 265
- Biotechnology 31
Countries citing papers authored by Benjamin Weigel
This map shows the geographic impact of Benjamin Weigel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Weigel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Weigel more than expected).
Fields of papers citing papers by Benjamin Weigel
This network shows the impact of papers produced by Benjamin Weigel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Weigel. The network helps show where Benjamin Weigel may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Weigel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 125 | |
| 2 | 1989 | 104 | |
| 3 | 2014 | 87 | |
| 4 | 2013 | 56 | |
| 5 | 1987 | 38 | |
| 6 | 1990 | 24 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 5 | |
| 9 | 1997 | 1 | |
| 10 | 1998 | 1 |
About Benjamin Weigel
Benjamin Weigel is a scholar working on Pharmacology, Molecular Biology, Rheumatology, Hematology and Cell Biology, having authored 10 papers that have together received 455 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), Plant biochemistry and biosynthesis (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Protease and Inhibitor Mechanisms (2 papers), Bacterial Genetics and Biotechnology (2 papers), Postharvest Quality and Shelf Life Management (1 paper), Blood properties and coagulation (1 paper) and Plant Pathogens and Fungal Diseases (1 paper). The work is most often cited by research in Molecular Medicine (50 citations), Pharmacology (156 citations), Microbiology (5 citations), Molecular Biology (265 citations) and Biotechnology (31 citations). Benjamin Weigel has collaborated with scholars based in Germany and United States. Frequent co-authors include Thomas D. Ingolia, Martin D. Tobin, S Kovacevic, James R. Miller, Stanley G. Burgett, Paul L. Skatrud, S. W. QUEENER, Charles A. Frolik, Ludger A. Wessjohann and Martin Dippe. Their work appears in journals such as Journal of Bacteriology, ChemBioChem, The Plant Cell, Journal of Biological Chemistry and Current Opinion in Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.